Biomarker discovery of spleen deficiency and dampness stagnation syndrome colorectal cancer based on metabonomics

Biomarker discovery of spleen deficiency and dampness stagnation syndrome colorectal cancer based on

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-CPC-14005311

Enrollment

Unknown

Registered

2014-09-30

Start date

2014-11-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Two groups:N/A

Eligibility

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Informed consent, volunteer, signed the informed consent; 2. With the western medicine of colorectal malignant tumor diagnosis standard; 3. In line with the traditional Chinese medicine spleen deficiency and dampness syndrome differentiation standard and the yin deficiency heat toxin stagnation; 4. Age between 18-80 years.

Exclusion criteria

Exclusion criteria: 1. The metastatic colorectal cancer; 2. The differentiation of non colorectal cancer patients of spleen deficiency and dampness stagnation and deficiency of heat toxin.

Design outcomes

Primary

Measure	Time frame
Biomarkers;	—

Countries

China

Contacts

Public ContactZhijun Fang

fangzjnj@hotmail.com+86 13372018676

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026